Stocks in play: Sirona Biochem Corp.

Reports that In Vitro studies completed on compounds developed by our scientists at TFChem have shown a strong potential for anti-cellulite activity. The data showed evidence for both the ability to reduce existing cellulite and to prevent the formation of new cellulite. The mechanism of action is technically complex involving a pro-lipolytic effect, a decrease of the adipocyte size and an anti-inflammatory effect. Sirona Biochem Corp. shares V.SBM are trading up $0.005 at $0.21.

Read:

• Where to Find Massive Growth in the Accelerating Esports Boom

• Food Industry Answering Growing Plant-Based Demands with Innovative Meatless Offerings

• Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

• Startling Statistics Point to a Desperate Need for Far Better Mental Health Care

• Here's What Happens When Two Multi-Billion Dollar Megatrends Collide